Blood-derived biomarkers for brain and spinal cord diseases are urgently needed. The
introduction of highly sensitive immunoassays led to a rapid increase in the number of …

The prevalence of autoimmune diseases (ADs) worldwide has rapidly increased over the
past few decades. Thus, in addition to the classical risk factors for ADs, such as genetic …

Background: High-quality epidemiologic data worldwide are needed to improve our
understanding of disease risk, support health policy to meet the diverse needs of people …

In the last ten years, there has been a growing interest regarding the relationship between
gut microbiota, brain, and neurological-associated affections. As multiple preclinical and …

Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) has been
emerging as a significant health issue worldwide. This study aimed to systemically assess …

Background Neurological disorders are increasingly recognised as major causes of death
and disability worldwide. The aim of this analysis from the Global Burden of Diseases …

Background Multiple sclerosis (MS) is a chronic, demyelinating disease of the central
nervous system that results in progressive and irreversible disability. Fatigue is one of the …

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system that
causes demyelination, axonal degeneration and astrogliosis, resulting in progressive …

Background and Objectives The goal of this work was to determine whether the prevalence
of multiple sclerosis (MS) varies by race and ethnicity. Methods We conducted a …

Multiple sclerosis (MS) is a demyelinating, autoimmune disease of the central nervous
system. While work has focused on myelin and axon loss in MS, less is known about …